FMCQF OTC
Fresenius Medical Care AG
1W: +0.0%
1M: -13.3%
3M: -0.0%
YTD: -4.2%
1Y: -13.1%
3Y: +9.2%
5Y: -30.9%
$44.58
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$19.6B
+1.5% ▲
5Y CAGR: +1.9%
Gross Profit
$5.0B
+5.7% ▲
5Y CAGR: -1.9%
Operating Income
$1.8B
+32.0% ▲
5Y CAGR: -4.4%
Net Income
$978M
+81.7% ▲
5Y CAGR: -3.4%
EPS (Diluted)
$3.35
+83.1% ▲
5Y CAGR: -3.3%
EBITDA
$3.4B
+5.9% ▲
5Y CAGR: -3.9%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $17.6B | $19.4B | $19.5B | $19.3B | $19.6B |
| YoY Growth | -1.3% | +10.1% | +0.3% | -0.6% | +1.5% |
| Cost of Revenue | $12.5B | $14.5B | $14.5B | $14.6B | $14.6B |
| Gross Profit | $5.1B | $4.9B | $4.9B | $4.8B | $5.0B |
| Gross Margin | 28.8% | 25.2% | 25.3% | 24.6% | 25.6% |
| R&D Expenses | $221M | $229M | $232M | $183M | $158M |
| SG&A Expenses | $3.1B | $3.2B | $3.2B | $3.1B | $3.0B |
| Operating Expenses | $3.3B | $3.4B | $3.6B | $3.4B | $3.2B |
| Operating Income | $1.9B | $1.5B | $1.4B | $1.4B | $1.8B |
| Operating Margin | 10.8% | 7.8% | 7.0% | 7.2% | 9.4% |
| Interest Expense | $354M | $360M | $425M | $407M | $385M |
| Income Before Tax | $1.6B | $1.2B | $1.0B | $1.1B | $1.5B |
| Tax Expense | $353M | $325M | $301M | $316M | $321M |
| Net Income | $969M | $673M | $499M | $538M | $978M |
| Net Margin | 5.5% | 3.5% | 2.6% | 2.8% | 5.0% |
| EPS (Diluted) | $3.31 | $2.30 | $1.70 | $1.83 | $3.35 |
| EBITDA | $3.4B | $3.4B | $3.2B | $3.2B | $3.4B |
| Shares Outstanding | 293M | 293M | 293M | 293M | 291M |